IBD & Intestinal Disorders
From the Journals
Budesonide topped placebo for treating lymphocytic colitis
Fully 79% of patients achieved clinical remission with budesonide.
From the Journals
Crohn’s disease tied to anal canal high-risk HPV infection
High-risk HPV DNA was detected in anal tissue specimens from 30% of patients with Crohn’s disease versus 18% of patients without Crohn’s disease...
From the Journals
H. pylori antibiotic resistance reaches ‘alarming levels’
Resistance to clarithromycin, metronidazole, and levofloxacin reached 15% or more in almost all World Health Organization regions.
From the Journals
Thiopurines linked to zoster in IBD patients
The adjusted hazard ratio for developing zoster was 1.47 (95% CI, 1.31-1.65; P less than .001) for thiopurine monotherapy, compared with...
The New Gastroenterologist
Advanced training options in inflammatory bowel disease
Advanced IBD concepts and training are often not covered adequately during a general gastroenterology fellowship.
Conference Coverage
Etrasimod improves clinical, endoscopic outcomes in patients with UC
PHILADELPHIA – A dose-response relationship was observed in the measures of treatment...
Conference Coverage
Low-FODMAP diet improves fecal incontinence in patients with loose stool
PHILADELPHIA – Formal dietary training about the diet reduced fecal incontinence.
Video
How to vaccinate patients on biologics
Conference Coverage
Treating IBD in medical home reduces costs
DALLAS – The medical home model can meet chronic disease patients’ complex, multidisciplinary needs – if the reimbursement challenges can be met...
From the Journals
Antibiotics trigger proteolytic activity that leads to chronic colitis
Antibiotics cause increased proteolytic activity in the large intestine that disrupts the gut barrier, increasing risk of chronic colitis.